Accugenix

What Accugenix does

Accugenix is a microbial identification and quality control brand operating as a wholly-owned business unit of Charles River Laboratories International, Inc. (NYSE: CRL), a publicly traded contract research organization headquartered in the United States. Founded in 1990 and based in Newark, Accugenix provides microbiology quality control solutions for contamination control and QC workflow optimization, primarily serving pharmaceutical and biopharmaceutical manufacturers. The brand is positioned as part of Charles River's broader Microbiology Quality Control Solutions portfolio, which sits inside the parent's full drug discovery and development continuum spanning basic research, discovery, preclinical testing, clinical development, and manufacturing/commercialization services.

The primary product offering is the Accugenix® Web Portal — a registered trademark and customer-facing platform hosted at myaccount.accugenix.com that enables enterprise clients to access microbial identification and testing services. The portal operates alongside Charles River's other customer-facing portals (Apollo™, ICM™, LTM™, Microbial Solutions Customer Portal, The Source™), reflecting tight integration with the parent's enterprise infrastructure. Services are distributed globally through Charles River's laboratory network and self-serve portal, targeting enterprise pharma manufacturers that require rapid, accurate, and compliant microbial testing. Underlying technology centers on microbial identification and quality control methods for contamination control; no proprietary AI/ML pipeline or differentiated software stack is disclosed.

Accugenix is not an independent operating entity; it is a product brand and customer portal under Charles River Laboratories. Revenue is generated through quote-based laboratory testing services typical of B2B contract research and QC work, but specific pricing, contract values, and Accugenix-level revenue figures are not publicly disclosed. The go-to-market is integrated into Charles River's established channels, including its corporate website, industry events (e.g., Biotech Symposium 2026), and scientific content platforms. The headcount figure of 10,000+ reflects the parent organization rather than Accugenix itself, and no independent funding rounds, investor base, or separate financial disclosures exist for the brand.

Name

Accugenix

Legal name

Charles River Laboratories International, Inc.

Website

https://accugenix.com

Company type

Private

Founded year

1990

Operating status

Operating

Headcount range

5,001–10,000 employees

Short description

Accugenix, founded in 1990, is a microbial identification and quality control brand under Charles River Laboratories, serving pharmaceutical and biopharmaceutical manufacturers through its Accugenix® Web Portal for testing and contamination control services.

Ownership category

akta.pro rank

Product category

Microbiology Quality Control Services

SIC

Services-Testing Laboratories (8734)

akta.pro primary industry

Microbiology & Sterility Assurance (Bioburden/Endotoxin/Sterility) (HLAGADAE)

akta.pro secondary industries

Environmental Monitoring & Cleanroom Testing (GMP) (HLAGADAL), Microbiology LIS/LIMS (HLACAMAD)

Keywords

• Microbial identification
• Contamination control
• Quality control testing
• Microbial strain typing
• QC laboratory services

Headquarters

HQ city

Newark

HQ country

United States

HQ region

North America

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Marketing or Sales

Distribution channels1 record

Marketing channels1 record

Core offering

Accugenix provides microbial identification and strain typing testing services for pharmaceutical and biopharmaceutical manufacturers, focusing on accurate and compliant methods for contamination control. The brand operates the Accugenix® Web Portal as a customer-facing platform for accessing microbial identification results and managing quality control workflows, operating as an integrated component of Charles River Laboratories' Microbiology Quality Control Solutions portfolio.

Product overview

Accugenix is a microbial identification and testing solutions brand under Charles River Laboratories. The primary product offering is the Accugenix® Web Portal, a customer-facing platform for accessing microbial testing and identification services. The brand specializes in providing microbiology quality control solutions for contamination control and QC workflows.

Differentiator

Problem solved

Functional benefit

Products and services

• Accugenix® Web Portal A customer web portal for Accugenix microbial solutions that enables pharmaceutical and biopharmaceutical manufacturing clients to access microbial identification and testing services and manage quality control testing results.

Segments1 record

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature1 record

Recent moves5 records

Expansion highlights4 records

Direct peers

• Nelson Labs: Sterility, microbiology, and contamination control testing laboratory serving medical device and pharmaceutical manufacturers with overlapping scope to Accugenix's biopharma QC testing focus.
• Bruker Corporation: Provider of the MALDI Biotyper microbial identification platform widely used in pharma QC labs. Bruker competes head-to-head with Accugenix for routine microbial ID workflows in regulated manufacturing environments.
• Eurofins Scientific: Global testing services network with significant pharmaceutical microbiology and sterility testing capabilities through Eurofins BioPharma Product Testing, directly competing with Accugenix for outsourced microbial QC contracts.
• bioMérieux: Global leader in industrial and clinical microbiology, offering microbial identification, environmental monitoring, and sterility testing solutions that directly compete with Accugenix's pharma/biopharma QC contamination control services.

Broad incumbents

• Becton, Dickinson and Company (BD): Major life sciences company offering microbiology identification and detection platforms (e.g., BD Phoenix, BD MAX) used in pharma and clinical QC labs. A broad incumbent with overlapping microbial ID capabilities.
• SGS: Global testing, inspection, and certification company offering microbiology and sterility testing across life sciences. Overlaps with Accugenix in pharma QC microbial testing within a much broader service portfolio.
• Thermo Fisher Scientific: Global life sciences tools and services company with microbiology products, lab services, and pharma services that intersect with Accugenix's microbial ID and QC offering through a much broader portfolio.
• Intertek: Global TIC provider with pharmaceutical services including microbiology and contamination control testing, comparable to Accugenix as part of a wider testing portfolio rather than a pure-play specialist.
• Labcorp Drug Development: Global central/biopharma lab services provider (formerly Covance) with microbiology and QC testing capabilities serving pharma manufacturers, overlapping with Accugenix as part of a much broader CRO and diagnostics portfolio.

Regional players

• WuXi AppTec: China-based global CRO/CDMO offering biologics testing services including microbiology. Comparable to Accugenix in pharma QC testing scope but with a primarily non-Western geographic footprint.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat5 records

Key risks4 records

Key highlights5 records

Customer concentration

• Xx.com/accugenix
• LinkedInlinkedin.com/company/accugenix-inc

Revenue estimate

Valuation estimate

Number of profiles

Profiles2 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Accugenix